P2X7 is one of the best characterized purinergic receptors in the context of cancer (73), including ovarian (74), mesothelioma (75), pancreatic cell (76), osteosarcoma cell (77), endometrial (78) and skin cancer (79, 80). Here, P2RX7 is linked to skin cancer.